Get started
Author

Rajesh Acharya

Virtual meetings promise to eliminate geographical and administrative barriers and increase accessibility, diversity and inclusivity
2021 · Juncheng Wu, Anushka Rajesh, et al. · Nature Biotechnology · 70
PDF
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck
2023 · Nicole N. Scheff, Marci L. Nilsen, et al. · Oral Oncology · 18
A novel humanized immune stroma PDX cancer model for therapeutic studies
2026 · Dongli Yang, Ian Beddows, et al. · Cancer Immunology Immunotherapy · 6
PDF
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression
2024 · Juliana Hofstätter Azambuja, Saigopalakrishna S. Yerneni, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Immu-12. Tumor Cell Ido Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2021 · Lijie Zhai, April Bell, et al. · Neuro-Oncology · 1
PDF
Functionally active lymphoid aggregates correlate with improved prognosis in brain metastases
2026 · Noor E. Nader, Alexandra R. Glathar, et al. · Cancer Discovery
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice
2026 · Juliana Hofstätter Azambuja, Saigopalakrishna S. Yerneni, et al. · Nature Communications
181 Functionally active lymphoid aggregates correlate with improved prognosis in melanoma brain metastases compared to lung adenocarcinoma brain metastases
2025 · Noor E Nader, Alexandra Glathar, et al. · Regular and Young Investigator Award Abstracts
PDF
Supplementary Table 1 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Data from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Supplementary Table 2 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Supplementary Figure 2 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Supplementary Table 3 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Supplementary Figure 1 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Supplementary Table 4 from Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
2024 · Lijie Zhai, April Bell, et al.
Tmic-03. Card9 Blockade Offers a New Opportunity to Reprogram Tumor-associated Macrophages in Glioblastoma
2024 · Juliana Hofstatter Azambuja, Saigopalakrishna Yerneni, et al. · Neuro-Oncology
PDF
Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism
2021 · Lijie Zhai, April Bell, et al. · Research Explorer (The University of Manchester)
Abstract PO-083: Utilizing spatial transcriptomics to elucidate tertiary lymphoid structure heterogeneity in human cancer
2020 · Dongyan Liu, Xiang Li, et al. · Cancer Research
Association between altered expression of key enzymes involved in kynurenine pathway with clinical outcome in patients with different grades of astrocytoma
2018 · D. Mohania, P. Kumar, et al. · Annals of Oncology
PDF
Works count: 19
Citation count: 100
H-index: 4
I10-index: 2
Year
Topic
Type